AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31857268
Drug: Anticoagulation medications
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoagulation medications
Trial: 24626851
Drug: Simeprevir 100
RxNorm normalized name: Simeprevir
DrugBank: Simeprevir (DB06290)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Simeprevir 100 mg QD with peginterferon and ribavirin for 24 weeks (SMV24)
Trial: 24626851
Drug: Simeprevir 100
RxNorm normalized name: Simeprevir
DrugBank: Simeprevir (DB06290)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Simeprevir 100 mg QD with peginterferon and ribavirin for 12 weeks (SMV12)
Trial: 14500804
Drug: Parathyroid hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Parathyroid hormone (1-84) 100 microg
Trial: 10663814
Drug: Fentanyl continuous
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl continuous infusion (2 microg/kg per h)
Trial: 9065133
Drug: Heparin and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin and low-dose aspirin
Trial: 6140541
Drug: Nicotinic acid
RxNorm normalized name: Nicotinic acid
DrugBank: Niacin (DB00627)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotinic acid 1 g orally in divided doses
Trial: 28158276
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (education, behavioral strategies, and oral laxatives).
Trial: 25998212
Drug: DA-3803 (test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DA-3803 (test formulation)
Trial: 19634573
Drug: metformin +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metformin + glimepirid (3 mg in the morning)
Trial: 17666915
Drug: Valsartan 80
RxNorm normalized name: valsartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 80 mg/day
Trial: 19958075
Drug: Irbesartan 150
RxNorm normalized name: irbesartan 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan 150 mg/day
Trial: 31947529
Drug: Capsinoids (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsinoids (9 mg daily for 3 months)
Trial: 30920398
Drug: Both steroid
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both steroid injection and KT
Trial: 28524341
Drug: Nitazoxanide 500
RxNorm normalized name: nitazoxanide 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitazoxanide 500 mg b.i.d., clarithromycin 500 mg b.i.d., and omeprazole 40 mg b.i.d. for 14 days
Trial: 28524341
Drug: Metronidazole 500
RxNorm normalized name: metronidazole 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole 500 mg b.i.d., clarithromycin 500 mg b.i.d., and omeprazole 40 mg b.i.d. for 14 days
Trial: 1098495
Drug: Oral dapsone
RxNorm normalized name: Dapsone
DrugBank: Dapsone (DB00250)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral dapsone (100 mg daily)
Trial: 1098495
Drug: Intramuscular acedapsone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular acedapsone (225 mg every 12 weeks)
Trial: 1098495
Drug: Oral dapsone
RxNorm normalized name: Dapsone
DrugBank: Dapsone (DB00250)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral dapsone (50 mg daily)
Trial: 31416698
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) injection of medetomidine (40 μg kg‐1)
Trial: 28884566
Drug: Propofol medium-long
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol medium-long chain lipid emulsion injection (100 mg initial dose, then 0.54 mg/kg/h for 24 hours)
Trial: 28884566
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no sedative measures)
Trial: 23154587
Drug: Olmesartan add-on
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan add-on therapy
Trial: 9166304
Drug: 1.5-g single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5-g single oral dose of metronidazole
Trial: 3908603
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no povidone iodine treatment)
Trial: 3908603
Drug: Combined trials
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined trials including povidone iodine treatment
Trial: 27277946
Drug: Daily multi-nutrient
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily multi-nutrient supplement (omega-3 fatty acids, calcium, selenium, B-11 vitamin, D-3 vitamin)
Trial: 25512294
Drug: Midpalatal mini-implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midpalatal mini-implant anchorage system
Trial: 25512294
Drug: Fixed appliance
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed appliance treatment with midpalatal mini-implant
Trial: 22382876
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose of CEA
Trial: 22382876
Drug: Anti-CEA IgA
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-CEA IgA antibodies
Trial: 17765378
Drug: yi‐gan san
FDA approved: no
EMA approved: no
PMDA approved: no
Description: yi‐gan san (YGS) at an average daily dosage of 6.4+/‐1.9 g (2.5‐7.5 g)
Trial: 7921530
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate inhalation aerosol via collapsible spacer
Trial: 7921530
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate inhalation aerosol via traditional large volume spacer
Trial: 2457710
Drug: Continuous subcutaneous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous subcutaneous infusion (CSCI) of hydromorphone (HM)
Trial: 28735699
Drug: Medication (sertraline)
RxNorm normalized name: Medicated Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (sertraline)
Trial: 24477837
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Cognitive Behavioral Therapy and Medication
Trial: 25935877
Drug: Losartan (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (50 mg when <50 kg, 100 mg otherwise)
Trial: 24283598
Drug: Lisinopril (ACE-inhibitor)
RxNorm normalized name: Lisinopril
DrugBank: Lisinopril (DB00722)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lisinopril (ACE-inhibitor)
Trial: 21737829
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of 1 ml of 5% hypertonic saline into biceps causing muscle pain
Trial: 19194214
Drug: Calculated High
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calculated High Dose (CHD, 6.66‐7.4 MBq/g)
Trial: 19194214
Drug: Calculated Low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calculated Low Dose (CLD, 3.33‐3.70 MBq/g)
Trial: 19194214
Drug: Fixed Low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed Low Dose (FLD, 481 MBq)
Trial: 9075106
Drug: Pulsed electromagnetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed electromagnetic frequency (PEMF) therapy combined with Birmingham Containment Splint
Trial: 9075106
Drug: Inactive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactive treatment coil (Control group)
Trial: 25465932
Drug: n-3 PUFAs
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 PUFAs (4 g/day)
Trial: 24140142
Drug: Intra-articular injection
RxNorm normalized name: PHOSPHORUS P-32 5 mCi in 1 mL INTRA-ARTICULAR INJECTION, SUSPENSION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular injection
Trial: 16040211
Drug: CEE 0.625
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE 0.625 mg plus MPA 2.5 mg daily orally for 12 months (hypertensive HRT group)
Trial: 16040211
Drug: CEE 0.625
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE 0.625 mg plus MPA 2.5 mg daily orally for 12 months (normotensive HRT group)
Trial: 6354007
Drug: Terbutaline sulfate
RxNorm normalized name: Terbutaline Sulfate
DrugBank: Terbutaline (DB00871)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Terbutaline sulfate aerosol (two sprays, four times a day for 14 weeks)
Trial: 6354007
Drug: Isoproterenol sulfate
RxNorm normalized name: Isoproterenol Sulfate
DrugBank: Isoprenaline (DB01064)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoproterenol sulfate aerosol (two sprays, four times a day for 14 weeks)
Trial: 30806102
Drug: CC plus
RxNorm normalized name: STATLOCK PICC PLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC plus metformin and L-carnitine
Trial: 30806102
Drug: CC plus
RxNorm normalized name: STATLOCK PICC PLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC plus metformin and placebo
Trial: 30806102
Drug: L-carnitine group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine group
Trial: 30379308
Drug: 7 mg
RxNorm normalized name: pectin 7 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 mg of astaxanthin (ASTX)
Trial: 30379308
Drug: 10 gr
RxNorm normalized name: Gelatin Capsules, 10 gr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 gr of DC and 7 mg of ASTX ingested simultaneously
Trial: 30379308
Drug: 10 gr
RxNorm normalized name: Gelatin Capsules, 10 gr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 gr of a lycosomal formulation of DC containing 7 mg of co‐crystalized ASTX (L‐DC‐ASTX)
Trial: 15809670
Drug: Intermittent androgen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent androgen deprivation therapy
Trial: 22931259
Drug: Continuous androgen
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous androgen deprivation therapy
Trial: 20673857
Drug: Myofascial Trigger
RxNorm normalized name: Anti-AML/SCCL-trigger monoclonal antibody
DrugBank: pM-81 (DB17432)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myofascial Trigger Point (MTrP) therapy plus modified PNF stretching
Trial: 15468166
Drug: Continuous androgen
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous androgen ablation after 14 months of protocol treatment
Trial: 15468166
Drug: Intermittent androgen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent androgen ablation after 14 months of protocol treatment
Trial: 15468166
Drug: 6 months
RxNorm normalized name: leuprolide 45 mg/6 months intramuscular kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 months of LHRH agonist with short-term antiandrogen treatment for flare-up prevention
Trial: 8961038
Drug: Naturalistic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naturalistic treatment conditions
Trial: 1743318
Drug: Both formulations
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both formulations (oral and vaginal)
Trial: 6812003
Drug: Pristinamycin (2-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pristinamycin (2-3 g/d)
Trial: 6812003
Drug: Oxacillin (4-6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxacillin (4-6 g/d)
Trial: 28052799
Drug: Albuterol MDPI
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol MDPI 90 μg per inhalation, two inhalations four times daily (total daily dose, 720 μg)
Trial: 11554430
Drug: Dopegyt solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopegyt solution (250 mg/50 ml)
Trial: 20944041
Drug: Topical permethrin
RxNorm normalized name: permethrin Topical Lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical permethrin (5% cream)
Trial: 20944041
Drug: 7% sulfur
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7% sulfur preparation
Trial: 8133853
Drug: Intravenous immune
RxNorm normalized name: Intravenous immune globulin (human)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immune globulin
Trial: 6998552
Drug: Clonidine, 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine, 0.05 mg twice daily
Trial: 30954330
Drug: Neuropattern oriented
RxNorm normalized name: Oriental melon
DrugBank: Muskmelon (DB15611)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuropattern oriented exploratory treatment (intervention group, IG)
Trial: 30954330
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care (treatment as usual, standard group, SG)
Trial: 26011509
Drug: CABG and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CABG and optimal medical therapy (MED)
Trial: 23803797
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (Control group) - 26 patients
Trial: 19347726
Drug: XM02 (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: XM02 (5 microg/kg/day, subcutaneous, for at least 5 days and a maximum of 14 days)
Trial: 19347726
Drug: Filgrastim (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Filgrastim (5 microg/kg/day, subcutaneous, for at least 5 days and a maximum of 14 days)
Trial: 17036619
Drug: Exercise and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise and cognitive-behavioral therapy
Trial: 12707157
Drug: Clonidine 15
RxNorm normalized name: chlorthalidone-clonidine 15 mg-0.1 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 15 micro g with bupivacaine 6 mg
Trial: 8574749
Drug: Pentoxifylline (PTX)
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (PTX) 5 mg/kg intravenous infusion over 180 min
Trial: 6452297
Drug: Topical erythromycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical erythromycin (1%) in a new penetrative vehicle
Trial: 25669083
Drug: Intercostal analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intercostal analgesia (ICA) with 2 ml x hr(‐1) of 0.2% ropivacaine and intravenous fentanyl (0.25 x μg(‐1). kg(‐1) x hr(‐1))
Trial: 25669083
Drug: Epidural analgesia
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural analgesia with 2 ml x hr(‐1) of 0.2% ropivacaine and intravenous fentanyl (0.25 x μg(‐1). kg(‐1) x hr(‐1))
Trial: 19001265
Drug: Intralymphatic allergen
RxNorm normalized name: catfish allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralymphatic allergen administration (3 injections over 2 months, cumulative allergen dose 3,000 SQ-U)
Trial: 19001265
Drug: Intralymphatic allergen
RxNorm normalized name: catfish allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralymphatic allergen administration
Trial: 19001265
Drug: s.c. immunotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: s.c. immunotherapy (54 injections over 3 years, cumulative allergen dose 4,031,540 SQ-U)
Trial: 16280777
Drug: Cyclosporine A
RxNorm normalized name: CycloSPORINE A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine A (CyA) 1.5 mg/kg twice daily
Trial: 16280777
Drug: Pentosan polysulfate
RxNorm normalized name: Pentosan polysulfate
DrugBank: Pentosan polysulfate (DB00686)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentosan polysulfate sodium (PPS) 100 mg 3 times daily
Trial: 12182757
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of intravenous erythromycin
Trial: 31414269
Drug: Sildenafil (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (0.5 mg/kg every 6 hours)
Trial: 25835642
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (600μg)
Trial: 25835642
Drug: Intramuscular oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular oxytocin (1mL of 10IU)
Trial: 19805689
Drug: Augmented therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Augmented therapy (intensive postinduction treatment)
Trial: 8326971
Drug: Anistreplase administered
RxNorm normalized name: Anistreplase
DrugBank: Anistreplase (DB00029)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anistreplase administered before admission (prehospital group)
Trial: 8326971
Drug: Anistreplase administered
RxNorm normalized name: Anistreplase
DrugBank: Anistreplase (DB00029)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anistreplase administered in the hospital (hospital group)
Trial: 27522312
Drug: 2% lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% lidocaine 2 ml only (control)
Trial: 20695899
Drug: Elemental diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elemental diet treatment
Trial: 18192787
Drug: Treatment of
RxNorm normalized name: DRUGS FOR TREATMENT OF LEPRA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment of T. vaginalis
Trial: 2580179
Drug: Captopril 50
RxNorm normalized name: captopril 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 50 mg + hydrochlorothiazide (HCTZ) 25 mg
Trial: 4010387
Drug: 3 X
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 X 75 mg pirlindol daily for two weeks
Trial: 4010387
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg pirlindol (single dose)
Trial: 4010387
Drug: 3 X
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 X 75 mg pirlindol (after one week treatment)
Trial: 4010387
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg and 225 mg pirlindol (superimposed dosage on days 8 and 15)
Trial: 31060037
Drug: Water Resistance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water Resistance Therapy (WRT)
Trial: 24136153
Drug: Darexaban 30
RxNorm normalized name: Darexaban
DrugBank: Darexaban (DB12289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darexaban 30 mg qd
Trial: 22952213
Drug: Darexaban 30
RxNorm normalized name: Darexaban
DrugBank: Darexaban (DB12289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darexaban 30 mg bid
Trial: 24136153
Drug: Darexaban 60
RxNorm normalized name: Darexaban
DrugBank: Darexaban (DB12289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darexaban 60 mg qd
Trial: 26052866
Drug: Darexaban 60
RxNorm normalized name: Darexaban
DrugBank: Darexaban (DB12289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darexaban 60 mg bid
Trial: 26052866
Drug: Darexaban 120
RxNorm normalized name: Darexaban
DrugBank: Darexaban (DB12289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darexaban 120 mg qd
Trial: 26052866
Drug: Warfarin qd
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin qd
Trial: 26052866
Drug: Darexaban (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darexaban (all doses)
Trial: 23584270
Drug: Gel group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gel group (control)
Trial: 31627998
Drug: Bisoprolol 8mg
DrugBank: Bisoprolol (DB00612)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Bisoprolol 8mg transdermal patch at bedtime
Trial: 30782208
Drug: Gyejigachulbutang (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gyejigachulbutang (2.5 g three times a day for 4 weeks)
Trial: 27326445
Drug: Prasugrel (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel (titrated dose)
Trial: 11516001
Drug: Immediate loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate loading of implants with overdentures
Trial: 3345278
Drug: Atracurium (effective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium (effective doses)
Trial: 20492850
Drug: Aspirin 1000
RxNorm normalized name: aspirin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 1000 mg/d
Trial: 18446591
Drug: School-based administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: School-based administration of preventive asthma medications with dose adjustments according to NHLBI guidelines and a home-based ETS reduction program utilizing motivational interviewing principles.
Trial: 16770112
Drug: Letrozole (Femara
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole (Femara tablet 2.5 mg)
Trial: 12727970
Drug: Estrogen replacement
RxNorm normalized name: Norethindrone Acetate 1mg, Ethinyl Estradiol 5mcg Oral tablet [Estrogen Replacement/Osteoporosis]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen replacement therapy with Premarin or a mixture of estrone and equilin sulfates for 3 months
Trial: 7943832
Drug: Propofol plus
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol plus fentanyl (0.2, 0.8, 1.5, 3.0, and 4.5 ng/ml)
Trial: 7943832
Drug: Propofol plus
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol plus fentanyl (greater than 3 ng/ml)
Trial: 28708736
Drug: Mifepristone 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone 1200 mg daily for 7 days